Skip to content

Public FDA record

Z-1517-2025: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987

Recall record Z-1517-2025 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1517-2025
Company in FDA record
Beckman Coulter Inc.
FDA classification date
Apr 3, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Beckman Coulter has determined that device software versions V1.3, V1.4, V1.4.1, V1.4.2, V1.4.3. have a defect due of which, when all constituent tests of a calculated result are rerun, either manually ordered by the operator at the analyzer or automatically triggered by predefined rules in System Configuration, the calculated result will not be recalculated using the constituent tests rerun results. The system will report only the calculated result using the initial constituent tests results to the operator and LIS/Remisol. The issue was identified by Beckman Coulter internal engineering testing. The defect may cause a delay in reporting patient results.

Source facts

Action
On 02/26/2025 and 3/10/2025, the firm send "URGENT MEDICAL DEVICE RECALL" Letters dated 2/20/2025 via email and postal mail to customer. The letter described the product, problem and actions to be taken. Customer are instruction to: . The calculated results can be recalculated manually offline by users based on the formula defined and rerun results from constituent tests. . Configure calculated tests within LIS/Middleware, if available. . Beckman Coulter recommends sharing the content of this letter with your laboratory and/or Medical Director. Any questions regarding this notice, contact our Customer Support Center: . From our website: http://www.beckmancoulter.com . Troubleshooting Hotline: (800) 854-3633
Initiated
2025-02-26
Root cause
Software design
Distribution
Worldwide Distribution: U.S. (nationwide) to states of: AL, CA, CO, GA, ID, IL, IN, LA, MA, AI, MN, MS, MT, NC, NM, NV, NY, OK, OR, PA, PR, SC, TN, TX, WA, and WI; O.U.S. (foreign) to countries of: Australia, Belgium, Bosnia/Herzegovina, Canada, Croatia, Egypt, Ethiopia, France, Germany, Ghana, India, Italy, Republic of Korea, Lebanon, Libya, Malaysia, Netherlands, North Macedonia, Oman, Paraguay, Philippines, Poland, Qatar, Saudi Arabia, Seychelles, Slovakia, South Africa, Spain and Switzerland
Recall number
Z-1517-2025
Recall status
Open, Classified
CDRH record ID
212861
FDA classified
2025-04-03
Recall event number
96430

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗